Galapagos Newsroom

Galapagos NV Unveils New Employee Incentive Plans

TipRanksMay 17 12:08 ET

Galapagos Creates New Subscription Right Plans

Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV ((Euronext &, NASDAQ:GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right

GlobeNewswireMay 16 16:01 ET

Galapagos NV Expands U.S. CAR-T Therapy Production

TipRanksMay 16 09:29 ET

Galapagos Partners With Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture

Galapagos (GLPG.AS) said Wednesday that it is collaborating with Blood Centers of America to decentralize the manufacture of its CAR-T cell therapies. The Belgian pharmaceutical research company will

MT NewswiresMay 16 01:02 ET

Galapagos and Blood Centers of America Announce Strategic Collaboration to Accelerate Galapagos' Decentralized CAR-T Manufacturing Network in the U.S.

BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centersCollaboration enables rapid deployment of

GlobeNewswireMay 15 16:01 ET

Express News | Galapagos NV : RBC Cuts Target Price to $35 From $38

ReutersMay 6 01:51 ET

Kepler Capital Sticks to Their Hold Rating for Galapagos (GLPG)

TipRanksMay 4 21:45 ET

Earnings Call Summary | Galapagos(GLPG.US) Q1 2024 Earnings Conference

The following is a summary of the Galapagos NV (GLPG) Q1 2024 Earnings Call Transcript:Financial Performance:Galapagos reported a net profit in Q1 2024 driven by adjustments in fair value, foreign exc

moomoo AIMay 4 13:29 ET · Conference Call

Galapagos First Quarter 2024 Earnings: EPS: €0.36 (Vs €0.35 in 1Q 2023)

Yahoo FinanceMay 4 02:14 ET

Galapagos NV Reports Strong Q1 2024 Financials

TipRanksMay 3 11:28 ET

Galapagos Reports Q1 Results

Seeking AlphaMay 2 16:58 ET

Galapagos Q1 EPS €1.40 Vs €0.40 YoY; Revenue €62.4 Million Vs €58.6 Million YoY

Results from our continuing operationsTotal operating loss from continuing operations for the three months ended 31 March 2024 was €33.1 million, compared to an operating loss of €14.2 million for the

BenzingaMay 2 16:37 ET

Galapogos: Reconfirmed 2024 Cash Burn Guidance of EUR280M to EUR320M, Not Including Potential Business Development Opportunities >GLPG.BT

Galapogos: Reconfirmed 2024 Cash Burn Guidance of EUR280M to EUR320M, Not Including Potential Business Development Opportunities >GLPG.BT

Dow JonesMay 2 16:03 ET

Galapogos 1Q EPS EUR1.40 >GLPG.BT

Galapogos 1Q EPS EUR1.40 >GLPG.BT

Dow JonesMay 2 16:03 ET

Galapagos NV Shareholders Approve Key Resolutions

TipRanksMay 1 07:30 ET

Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024

Mechelen, Belgium; 30 April 2024, 22:01 CET; Galapagos NV ((Euronext &, NASDAQ:GLPG) today announces that all resolutions proposed at the company's Annual and Extraordinary Shareholders' Meetings (AGM and EGM) held on

GlobeNewswireApr 30 16:01 ET

Express News | Morgan Stanley Maintains Equal-Weight on Galapagos, Maintains $38 Price Target

Moomoo 24/7Apr 22 13:23 ET

LG LAUNCHES VULNERABLE & ENDANGERED SPECIES AWARENESS CAMPAIGN IN TIMES SQUARE

3D anamorphic animal series kicks off LG's Earth Day activations; LG commits $150,000 in partnership with the National Wildlife Federation and Discovery EducationNEW YORK, April 16, 2024 /PRNewswire/

PR NewswireApr 16 12:00 ET

Galapagos NV Unveils CAR-T Therapy Advances

TipRanksApr 8 10:27 ET

Galapagos Showcases Innovative Approach in Hematological Cancer Care With Clinical and Translational Data Presentations at EBMT Congress 2024

Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen,

GlobeNewswireApr 4 16:01 ET